This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Bounthavong M, Hsu DI, Okamoto MP.Cost-effectiveness analysis of linezolid vs. vancomycin in treating methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections using a decision analytic model. International Journal of Clinical Practice 63: 376-386, No. 3, Mar 2009
Rights and permissions
About this article
Cite this article
Vancomycin shows cost effectiveness against MRSA SSIs. Pharmacoecon. Outcomes News 578, 9 (2009). https://doi.org/10.2165/00151234-200905780-00020
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905780-00020